A method for enhancing recombinant antibody production by co-expressing a recombinant antibody with the ERp23 protein. The ERp23 protein facilitates oxidative folding and stability of the recombinant antibody which enhances its production. This invention may be used in the production of therapeutic antibodies.
Therapeutic antibody production
Granted Patents or Published Applications
U.S. Patent No. 8,030,0027
Related Scientific References
Shimizu Y, Meunier L, Hendershot LM; pERp1 is significantly up-regulated during plasma cell differentiation and contributes to the oxidative folding of immunoglobulin. Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17013-8.
We are currently seeking licensing opportunities in all fields for the development of this technology.
Contact the Office of Technology Licensing (Phone: 901-595-2342, Fax: 901-595-3148) for more information.